Latest Liquidity News

Gateway Mining Limited's trading suspension has been lifted following the release of new exploration results from its Yandal Gold Project, reopening market access for investors.

Gateway Mining has identified approximately 90 kilometres of previously untested shear zones at its Yandal Gold Project in Western Australia, setting the stage for significant new gold exploration. The company plans major drilling campaigns in the coming months to unlock this potential.

ASIC has initiated civil proceedings against Equity Trustee Superannuation Limited, alleging failures in due diligence and monitoring related to the Shield Master Fund. Equity Trustees is cooperating with ASIC and supporting affected members while reviewing the claims.

Fluence Corporation has agreed with its revolving lenders, who are also board members, to convert $1.8 million of accrued interest into shares, pending shareholder approval. This move aims to preserve cash and enhance operational flexibility as the company pursues growth.

Scentre Group reported a 3.2% rise in Funds From Operations for H1 2025 and upgraded its full-year distribution guidance, driven by record occupancy and retail sales growth across its Westfield portfolio.

Scentre Group reported a robust half-year result with profit after tax surging to $782.2 million and Funds From Operations rising 3.2%, underpinned by strong retail sales and near-record occupancy. The Group also advanced a $4 billion development pipeline and sold a 25% stake in Westfield Chermside, maintaining management control.

Neurizon Therapeutics reported a $16.6 million loss for FY2025 amid significant progress in its lead neurodegenerative therapy NUZ-001, including regulatory milestones and a global licensing deal. The company is poised to enter a pivotal ALS clinical trial pending FDA clearance.

Lake Resources N.L. has updated its Kachi Phase One DFS Addendum, showcasing improved lithium brine grades, enhanced extraction technology, and stronger project economics, positioning the Kachi lithium project closer to development.

Ingenia Communities Group has reported a robust FY25 performance, exceeding underlying EPS guidance with a 33% increase and signalling strong momentum heading into FY26.

Integral Diagnostics (IDX) reported a robust FY25 with 33.7% revenue growth and operating EBITDA margin expansion, driven by the Capitol merger and organic growth. The company exceeded synergy expectations and outlined a confident outlook amid favourable industry tailwinds.

Integral Diagnostics posts robust FY25 results with strong revenue growth and merger synergies exceeding expectations, setting a confident tone for FY26.

Integral Diagnostics Limited (ASX – IDX) reported a robust FY25 performance, boosted by its transformative merger with Capitol Health Limited. The company posted strong revenue and profit growth, declared a 4.0 cent final dividend, and outlined strategic priorities including AI adoption and teleradiology expansion.